Michaela Hrdlickova

Michaela has been involved in the pharmaceutical industry since 1995. Between 2010–2017, she was Country Director of Biogen, Czech Republic. Since 2011 I has held the position of Vice President of the Association of Innovative Pharmaceutical Industry. In 2017-2019, Michaela led the international team responsible for a specific therapeutic area in Central/Eastern Europe. Currently, Michaela is the Director of Patient Advocacy for Canada/Europe/Partner Markets in Spinal muscular atrophy, a member of Biogen’s Global Corporate Affairs team.

Michaela is considered as an expert in the field of biotechnology, in the pharmaceutical industry and in work with patient organizations.

In Michaela’s career in the pharmaceutical industry, she has built and led several very successful teams, launched several new drugs, and initiated several projects that have had a broader social impact. Michaela strengths are negotiation and the ability to find ways to solve often very complicated situations. She passes on her vision to the people in her teams. She listen to them and give them confidence and space to realize themselves.

Michaela is a member of Business Professional Women. She regularly cooperate as a mentor at Equal Pay Day, activities promoting cooperation and equal opportunities for women and men, older and younger generations.

Michaela is the initiator of the project of the Academy of Patient Organizations (APO), which has been very successfully implemented by AIFP (Association of Innovative Pharmaceutical Industry) since 2011. This project has helped many patient organizations to become independent, professional and respected partners of healthcare institutions.

In the years 2016 - 2020, Michaela repeatedly ranked among the finalists in the TOP Women ranking organized by the Economia publishing house. In 2019, 2020, she was listed among the most influential women in the Czech Republic according to Forbes magazine.